Tommasi Ruben
Insider CIK 1751824 · ETTX Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 98,700 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 6,465 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 24,858 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | J Other deriv | 2022-07-11 | 2022-07-11 | 50,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer | 2022-07-11 | 2022-07-11 | 150,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | U Tender | 2022-07-07 | 2022-07-11 | 39,596 | $2.20 | $87.1K | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2022-01-18 | 2022-01-19 | 125,000 | — | $0 | 189,596 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | F Tax w/h | 2021-11-02 | 2021-11-03 | 3,669 | $2.94 | $10.8K | 64,596 | SEC↗ |
| [ETTX] Entasis Therapeutics Holdi | A Award | 2021-10-19 | 2021-10-20 | 25,000 | — | $0 | 72,024 | SEC↗ |
| [ETTX] Entasis Therapeutics Holdi | S Sale | 2021-10-19 | 2021-10-20 | 3,759 | $3.19 | $12.0K | 68,265 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 12,024 | — | $0 | 12,024 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 56,500 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 28,006 | — | $0 | 28,006 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 50,411 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 43,460 | — | $0 | 43,460 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 15,632 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2021-07-16 | 2022-02-15 | 15,210 | — | $0 | 15,210 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | D To issuer deriv | 2021-07-16 | 2022-02-15 | 22,816 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award | 2021-01-15 | 2021-01-19 | 25,000 | — | $0 | 47,024 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2020-01-23 | 2020-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2019-01-18 | 2019-01-22 | 56,500 | — | $0 | 56,500 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | M Exercise deriv | 2018-12-21 | 2018-12-26 | 10,236 | — | $0 | 24,858 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | M Exercise deriv | 2018-12-21 | 2018-12-26 | 11,788 | — | $0 | 6,465 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | M Exercise | 2018-12-21 | 2018-12-26 | 10,236 | $3.11 | $31.8K | 22,024 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | M Exercise | 2018-12-21 | 2018-12-26 | 11,788 | $3.74 | $44.1K | 11,788 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2018-09-25 | 2018-09-27 | 50,411 | — | $0 | 50,411 | SEC↗ |